Suppr超能文献

国际医疗保健组织与融资研究:德国肾脏替代治疗的发展

International study of health care organization and financing: development of renal replacement therapy in Germany.

作者信息

Kleophas Werner, Reichel Helmut

机构信息

Dialysis Center Karlstrasse, Karlstr. 17-19, Duesseldorf, 40210, Germany.

出版信息

Int J Health Care Finance Econ. 2007 Sep;7(2-3):185-200. doi: 10.1007/s10754-007-9020-0.

Abstract

The German health system represents the case of a global budget with negotiated fees and competing medical insurance companies. Physicians in private practice and non-profit dialysis provider associations provide most dialysis therapy. End-stage renal disease (ESRD) modalities are well integrated into the overall health care system. Dialysis therapy, independent of the mode of treatment, is reimbursed at a weekly flat rate. Mandatory health insurance covers health expenses, including those related to ESRD, for more than 90% of the population. Both employees and employers contribute to the premium for this insurance. Private medical insurance covers the remainder of the population. Access to treatment, including dialysis therapy, is uniformly available.

摘要

德国医疗体系体现了一种全球预算模式,采用协商收费且存在相互竞争的医疗保险公司。私人执业医生和非营利性透析服务提供商协会提供了大部分透析治疗服务。终末期肾病(ESRD)治疗方式很好地融入了整体医疗保健系统。无论治疗方式如何,透析治疗均按每周固定费率报销。强制性医疗保险覆盖了超过90%人口的医疗费用,包括与终末期肾病相关的费用。雇员和雇主都为该保险的保费做出贡献。私人医疗保险覆盖其余人口。包括透析治疗在内的治疗服务可统一获得。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验